PROTECTIVE EFFECT OF THE BISPIPERAZINEDIONE ICRF-187 AGAINST DOXORUBICIN-INDUCED CARDIAC TOXICITY IN WOMEN WITH ADVANCED BREAST-CANCER

被引:337
作者
SPEYER, JL
GREEN, MD
KRAMER, E
REY, M
SANGER, J
WARD, C
DUBIN, N
FERRANS, V
STECY, P
ZELENIUCHJACQUOTTE, A
WERNZ, J
FEIT, F
SLATER, W
BLUM, R
MUGGIA, F
机构
[1] NYU MED CTR,DEPT MED,DIV CARDIOL,NEW YORK,NY 10016
[2] NYU MED CTR,DEPT RADIOL,DIV NUCL MED,NEW YORK,NY 10016
[3] NYU MED CTR,INST ENVIRONM MED,EPIDEMIOL & BIOSTAT LAB,NEW YORK,NY 10016
[4] NHLBI,ULTRASTRUCT PATHOL BRANCH,BETHESDA,MD 20205
关键词
D O I
10.1056/NEJM198809223191203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:745 / 752
页数:8
相关论文
共 47 条
[41]  
WADLER S, 1986, CANCER RES, V46, P1176
[42]   REDUCTION OF DAUNOMYCIN TOXICITY BY RAZOXANE [J].
WANG, G ;
FINCH, MD ;
TREVAN, D ;
HELLMANN, K .
BRITISH JOURNAL OF CANCER, 1981, 43 (06) :871-877
[43]  
WEISS AJ, 1976, CANCER TREAT REP, V60, P813
[44]  
WEISS RB, 1986, CANCER CHEMOTH PHARM, V18, P185
[45]  
WHEELER R H, 1983, Investigational New Drugs, V1, P283
[46]  
WOODMAN RJ, 1975, CANCER CHEMOTH REP 1, V59, P689
[47]  
1979, NOMENCLATURE CRITERI